ZTS

Zoetis Inc

• Simply Wall St·16h ago

  How Lenivia’s Long-Acting Canine OA Launch At Zoetis (ZTS) Has Changed Its Investment Story

• NASDAQ·1d ago

  Friday's ETF with Unusual Volume: FTXH

• PR Newswire·1d ago

  Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

• Simply Wall St·1d ago

  Zoetis (ZTS) Launches New Pet Pain Treatments As Valuation Questions Return

• Seeking Alpha·1d ago

  Why Dividend Investing Often Wins

• Seeking Alpha·1d ago

  Zoetis: Sentiment Keeps Winning As Fundamentals Improve

• Dow Jones·3d ago

  Zoetis Is Maintained at Overweight by Morgan Stanley

• Dow Jones·3d ago

  Zoetis Price Target Cut to $99.00/Share From $115.00 by Morgan Stanley

• Benzinga·3d ago

  Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $99

• TipRanks·3d ago

  Zoetis price target lowered to $99 from $115 at Morgan Stanley

• TipRanks·3d ago

  Zoetis launches Portela in Canada, the EU

• Benzinga·3d ago

  Zoetis Commercially Rolls Out Portela In Canada, EU To Treat Pain Associated With Osteoarthritis

• PR Newswire·4d ago

  Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

• PR Newswire·5d ago

  ZTS Deadline: ZTS Investors with Loses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

• TipRanks·5d ago

  Unusually active option classes on open July 20th